Cornelia Alida Van Egmond

Title: Cornelia Alida Van Egmond: Innovator in Pharmaceutical Administration

Introduction

Cornelia Alida Van Egmond is a notable inventor based in Haarlem, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. Her work focuses on improving the efficacy and cost-effectiveness of medication administration.

Latest Patents

Cornelia holds a patent for a solid form of oral administration of isosorbide 5-mononitrate. This innovative formulation features a controlled, pH-independent release of the active substance in the gastrointestinal tract. The patented design consists of a pellet coated with a depot layer and a release-prolonging lacquer layer. The lacquer layer is composed of ethyl cellulose and polymethacrylate in a weight ratio ranging from 3:1 to 3:2. This new form of administration is characterized by its reduced production costs, making it a valuable advancement in pharmaceutical technology.

Career Highlights

Cornelia is associated with Byk Gulden Lomberg Chemische Fabrik GmbH, where she applies her expertise in pharmaceutical development. Her innovative approach has led to advancements that benefit both manufacturers and patients alike.

Collaborations

Cornelia has collaborated with notable colleagues, including Sibo Wytse De Jong and Jan Bron. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Cornelia Alida Van Egmond's contributions to pharmaceutical administration exemplify the impact of innovation in healthcare. Her work not only enhances drug delivery systems but also emphasizes the importance of cost-effective solutions in the industry.